November 13, 2018
Via: ForbesAt its annual R&D investor day, Novartis updated the world on its drug pipeline and research priorities. It was an impressive session befitting a company that spends $9 billion annually on R&D (about 18% of its top line revenues). Novartis […]
March 28, 2024
April 19, 2024